Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Equity Average (2016 - 2025)

Historic Equity Average for Usana Health Sciences (USNA) over the last 16 years, with Q3 2025 value amounting to $529.6 million.

  • Usana Health Sciences' Equity Average rose 132.39% to $529.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $529.6 million, marking a year-over-year increase of 132.39%. This contributed to the annual value of $514.7 million for FY2024, which is 1047.97% up from last year.
  • Latest data reveals that Usana Health Sciences reported Equity Average of $529.6 million as of Q3 2025, which was up 132.39% from $530.4 million recorded in Q2 2025.
  • In the past 5 years, Usana Health Sciences' Equity Average ranged from a high of $532.6 million in Q4 2024 and a low of $392.5 million during Q2 2022
  • In the last 5 years, Usana Health Sciences' Equity Average had a median value of $453.5 million in 2023 and averaged $459.3 million.
  • Its Equity Average has fluctuated over the past 5 years, first soared by 2616.19% in 2021, then plummeted by 702.93% in 2022.
  • Quarter analysis of 5 years shows Usana Health Sciences' Equity Average stood at $408.9 million in 2021, then increased by 3.41% to $422.8 million in 2022, then rose by 14.43% to $483.8 million in 2023, then grew by 10.09% to $532.6 million in 2024, then dropped by 0.57% to $529.6 million in 2025.
  • Its Equity Average stands at $529.6 million for Q3 2025, versus $530.4 million for Q2 2025 and $530.9 million for Q1 2025.